Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 13/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17754264 | 0.91 | FFAR1 (0.34) | AKR1C3THRBFFAR1 | |
| SCHEMBL15582416 | 0.89 | THRB (0.38) | AKR1C3THRBFFAR1PPARD | |
| SCHEMBL17754249 | 0.87 | THRB (0.43) | AKR1C3THRB | |
| SCHEMBL17754262 | 0.85 | THRB (0.39) | AKR1C3THRB | |
| SCHEMBL16803374 | 0.84 | THRB (0.42) | AKR1C3THRB | |
| SCHEMBL20174160 | 0.82 | THRB (0.42) | AKR1C3THRBFFAR1 | |
| SCHEMBL21556855 | 0.80 | KMT2A (0.42) | AKR1C3THRBFFAR1 | |
| SCHEMBL18541166 | 0.80 | THRB (0.39) | AKR1C3THRB | |
| SCHEMBL20105023 | 0.80 | FFAR1 (0.41) | AKR1C3THRBFFAR1PPARD | |
| SCHEMBL17754252 | 0.80 | FFAR4 (0.35) | AKR1C3THRBFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | DIC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | RCC1, LPXN, SMC4 | AKR1C3 2593/4885THRB 4879/4885FFAR1 1525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.